FundedIQ
Artificial Intelligence

Scala Biodesign: Funding, Investors & Team (Sep 2026)

The unique computational solution provided by Scala Biodesign enhances the worth of proteins and speeds up their progress into marketable products, setting it apart from other offerings.

www.scala-bio.com LinkedIn Tel Aviv, Israel 1-10 employees
Artificial Intelligence Biotechnology Machine Learning
Total raised
$21.5M
Rounds
2
Latest
Series A
Mar 2026

Scala Biodesign has raised $21.5M across 2 funding rounds on record, the most recent a Series A of $16.0M announced in Mar 2026.

That round is above the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Scala Biodesign Company Profile and Key Stats

Total funding raised
$21.5M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$16.0M in Mar 2026
Employees
1-10
reported band
Headquarters
Tel Aviv, Israel

Latest funding round on record: Mar 2026.

Scala Biodesign Funding Rounds

Date
Round
Amount
Series A
$16.0M
Seed
$5.5M

Scala Biodesign raised $5.5M in a Seed announced in Sep 2023.

2.5 years later, a Series A of $16.0M was announced in Mar 2026.

Scala Biodesign Founders and Leadership Team

Name
Role
Contact
Adi Goldenzweig
Founder
Locked
Ravit Netzer
Founder
Locked

Contact details for the Scala Biodesign team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Scala Biodesign Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round
1,012
$13M
8,352
$15M

Scala Biodesign's latest round of $16.0M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Scala Biodesign in Artificial Intelligence and Tel Aviv

Companies Similar to Scala Biodesign

Faye provides whole-trip travel coverage and care that brings out the best in each journey with…

Series C $50.0M

Arato.ai is an advanced AI agent simulation platform that helps organizations test, evaluate, and monitor…

Seed $10.0M

Kinoa provides an AI-powered LiveOps platform that helps mobile app and game companies manage user…

Undisclosed round $10.0M

Dream Security is a cybersecurity firm that creates artificial intelligence products to safeguard against…

Series C $260M

SuperBuzz (TSXV: SPZ) utilizes cutting-edge GPT-3 technology, such as chatGPT, to produce targeted content…

Undisclosed round $360k

Limitless Labs is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM…

Series A $20.0M

NewCore is a security-first identity platform that governs every human and AI agent identity for the…

Series A $50.0M

Odysight.AI is an AI platform that specializes in visualizing, analyzing, predictive maintenance, and…

Undisclosed round $20.0M

Arito is an AI-powered finance platform that helps teams automate reporting, analyze data, and generate…

Seed $6.0M

Cybord creates technologies that prevent fake, substandard, and harmful electronic parts from being…

Series A $7.0M

The ThirdEye Team believes that today's drones have amazing capabilities and should be accessible by almost…

Undisclosed round $10.0M

With Sett's advanced AI technology, it can analyze various types of data such as live campaign data,…

Series B $30.0M

Scala Biodesign Funding FAQs

What does Scala Biodesign do?

The unique computational solution provided by Scala Biodesign enhances the worth of proteins and speeds up their progress into marketable products, setting it apart from other offerings.

How much funding has Scala Biodesign raised?

Scala Biodesign has raised $21.5M across 2 rounds on record. The most recent is a Series A of $16.0M announced in Mar 2026.

When did Scala Biodesign last raise funding?

Scala Biodesign's most recent funding round on record is a Series A of $16.0M, announced in Mar 2026.

Who founded Scala Biodesign?

FundedIQ lists Adi Goldenzweig (Founder), Ravit Netzer (Founder) at Scala Biodesign.

Where is Scala Biodesign headquartered?

Scala Biodesign is based in Tel Aviv, Israel.

How many employees does Scala Biodesign have?

Scala Biodesign is in the 1-10 employee band.

How does Scala Biodesign's funding compare to other Artificial Intelligence startups?

Scala Biodesign's latest round of $16.0M is above the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Scala Biodesign Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Scala Biodesign is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.